Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression
Abstract
:1. Introduction
2. Materials and Methods
2.1. Literature Search
2.2. Excluded Studies
2.3. Validity Assessment
2.4. Data Extraction
2.5. Statistical Analysis
3. Results
3.1. Study Characteristics, Quality and Bias Assessment
Author, Year | Country (Study) | Population | Baseline Population | Participant Cases | Sex | Assessment (Exposure) | Key Set of Covariates 1 |
---|---|---|---|---|---|---|---|
Study Design | Mean Age | Definition (Outcome) | |||||
Song et al., 2005 [20] | USA (WHS) | Population-based | Healthy | 9907 | F | FFQ | + |
Cross-sectional | 2418 | 52 | Modified NCEP-ATP III | ||||
Bo et al., 2006 [21] | Italy | Population-based | Healthy | 1653 | M and F | FFQ | + |
Cross-sectional | 384 | 54 | NCEP-ATP III | ||||
He et al., 2006 [19] | USA (CARDIA) | Population-based | Healthy | 4637 | M and F | FFQ | ++ |
Prospective cohort | 608 | 25 | NCEP-ATP III | ||||
Ford et al., 2007 [18] | USA (NHANES III) | Population-based | Healthy | 7669 | M and F | 24-h recall | + |
Cross-sectional | 4965 | 44 | NCEP-ATP III | ||||
McKeown et al., 2008 [34] | USA | Population-based | Healthy | 535 | M and F | 3-D food record | ++ |
Cross-sectional | 212 | 72 | Modified NCEP-ATP III | ||||
Noori, 2010 [22] | Iran | Hospital-based | Renal-transplant recipient | 160 | M and F | FFQ | + |
Prospective cohort | 58 | 40 | NCEP-ATP III | ||||
Huang et al., 2012 [29] | Taiwan | Hospital-based | Diabetes | 210 | M and F | 24-h recall | ++ |
Cross-sectional | 156 | 72 | NCEP-ATP III | ||||
Al-Daghri et al., 2013 [32] | Saudi Arabia | Population-based | Healthy | 185 | M and F | 24-h recall | + |
Cross-sectional | 72 | 26 | IDF | ||||
Choi et al., 2013 [33] | Korea (KNHANES IV) | Population-based | Healthy | 2084 | M | 24-h recall | + |
540 | 44 | Modified NCEP-ATP III | |||||
Cross-sectional | 3052 | F | |||||
748 | 49 |
3.2. Meta-Regression and Dose-Response Meta-Analysis
3.3. Subgroup Analyses and Publication Bias
4. Discussion
5. Conclusions
Supplementary Files
Supplementary File 1Acknowledgments
Author Contributions
Conflicts of Interest
References
- Reaven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37, 1595–1607. [Google Scholar] [CrossRef] [PubMed]
- Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef] [PubMed]
- Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113–1132. [Google Scholar] [CrossRef] [PubMed]
- Wu, S.H.; Liu, Z.; Ho, S.C. Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. Eur. J. Epidemiol. 2010, 25, 375–384. [Google Scholar] [CrossRef] [PubMed]
- Andersen, C.J.; Fernandez, M.L. Dietary strategies to reduce metabolic syndrome. Rev. Endocr. Metab. Disord. 2013, 14, 241–254. [Google Scholar] [CrossRef] [PubMed]
- Barbagallo, M.; Dominguez, L.J.; Galioto, A.; Ferlisi, A.; Cani, C.; Malfa, L.; Pineo, A.; Busardo, A.; Paolisso, G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol. Asp. Med. 2003, 24, 39–52. [Google Scholar] [CrossRef]
- Elin, R.J. Magnesium: The fifth but forgotten electrolyte. Am. J. Clin. Pathol. 1994, 102, 616–622. [Google Scholar] [PubMed]
- Katcher, H.I.; Legro, R.S.; Kunselman, A.R.; Gillies, P.J.; Demers, L.M.; Bagshaw, D.M.; Kris-Etherton, P.M. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 79–90. [Google Scholar] [PubMed]
- Guerrera, M.P.; Volpe, S.L.; Mao, J.J. Therapeutic uses of magnesium. Am. Fam. Phys. 2009, 80, 157–162. [Google Scholar]
- Thomas, D. The mineral depletion of foods available to us as a nation (1940–2002)—A review of the 6th edition of mccance and widdowson. Nutr. Health 2007, 19, 21–55. [Google Scholar] [CrossRef] [PubMed]
- Turner, R.E.; Langkamp-Henken, B.; Littell, R.C.; Lukowski, M.J.; Suarez, M.F. Comparing nutrient intake from food to the estimated average requirements shows middle- to upper-income pregnant women lack iron and possibly magnesium. J. Am. Diet. Assoc. 2003, 103, 461–466. [Google Scholar] [PubMed]
- Volpe, S.L. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit. Rev. Food Sci. Nutr. 2008, 48, 293–300. [Google Scholar] [CrossRef] [PubMed]
- Barbagallo, M.; Dominguez, L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 2007, 458, 40–47. [Google Scholar] [CrossRef] [PubMed]
- Corica, F.; Corsonello, A.; Ientile, R.; Cucinotta, D.; Di Benedetto, A.; Perticone, F.; Dominguez, L.J.; Barbagallo, M. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J. Am. Coll. Nutr. 2006, 25, 210–215. [Google Scholar] [CrossRef] [PubMed]
- Guerrero-Romero, F.; Rodríguez-Morán, M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002, 39, 209–213. [Google Scholar] [CrossRef] [PubMed]
- Guerrero-Romero, F.; Rodríguez-Morán, M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab. Res. Rev. 2006, 22, 471–476. [Google Scholar] [CrossRef] [PubMed]
- Yu, Y.; Cai, Z.; Zheng, J.; Chen, J.; Zhang, X.; Huang, X.F.; Li, D. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr. Res. 2012, 32, 71–77. [Google Scholar] [CrossRef] [PubMed]
- Ford, E.S.; Li, C.; McGuire, L.C.; Mokdad, A.H.; Liu, S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. Adults. Obesity 2007, 15, 1139–1146. [Google Scholar] [CrossRef] [PubMed]
- He, K.; Liu, K.; Daviglus, M.L.; Morris, S.J.; Loria, C.M.; van Horn, L.; Jacobs, D.R., Jr.; Savage, P.J. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113, 1675–1682. [Google Scholar] [CrossRef] [PubMed]
- Song, Y.; Ridker, P.M.; Manson, J.E.; Cook, N.R.; Buring, J.E.; Liu, S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005, 28, 1438–1444. [Google Scholar] [CrossRef] [PubMed]
- Bo, S.; Durazzo, M.; Guidi, S.; Carello, M.; Sacerdote, C.; Silli, B.; Rosato, R.; Cassader, M.; Gentile, L.; Pagano, G. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am. J. Clin. Nutr. 2006, 84, 1062–1069. [Google Scholar] [PubMed]
- Noori, N.; Nafar, M.; Poorrezagholi, F.; Ahmadpoor, P.; Samadian, F.; Firouzan, A.; Einollahi, B. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J. Ren. Nutr. 2010, 20, 101–111. [Google Scholar] [CrossRef] [PubMed]
- Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009, 339, b2700. [Google Scholar] [CrossRef]
- Kim, S.Y.; Park, J.E.; Lee, Y.J.; Seo, H.J.; Sheen, S.S.; Hahn, S.; Jang, B.H.; Son, H.J. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J. Clin. Epidemiol. 2013, 66, 408–414. [Google Scholar] [CrossRef] [PubMed]
- DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177–188. [Google Scholar] [CrossRef] [PubMed]
- Thompson, S.G.; Higgins, J.P. How should meta-regression analyses be undertaken and interpreted? Stat. Med. 2002, 21, 1559–1573. [Google Scholar] [CrossRef] [PubMed]
- Greenland, S.; Longnecker, M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992, 135, 1301–1309. [Google Scholar] [PubMed]
- Symons, M.J.; Moore, D.T. Hazard rate ratio and prospective epidemiological studies. J. Clin. Epidemiol. 2002, 55, 893–899. [Google Scholar] [CrossRef] [PubMed]
- Huang, J.H.; Lu, Y.F.; Cheng, F.C.; Lee, J.N.; Tsai, L.C. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: A cross-sectional study. Nutr. J. 2012, 11, 41. [Google Scholar] [CrossRef] [PubMed]
- Tsou, M.T. Metabolic syndrome in metabolic obese, non-obese elderly in northern Taiwan. Adv. Aging Res. 2012, 1, 53–59. [Google Scholar] [CrossRef]
- Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Daghri, N.M.; Khan, N.; Alkharfy, K.M.; Al-Attas, O.S.; Alokail, M.S.; Alfawaz, H.A.; Alothman, A.; Vanhoutte, P.M. Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in saudi arabia: A pilot study. Nutrients 2013, 5, 4587–4604. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Choi, M.K.; Bae, Y.J. Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in korean adults: The Korea National Health And Nutrition Examination Survey (2007–2008). Biol. Trace Elem. Res. 2013, 156, 56–66. [Google Scholar] [CrossRef] [PubMed]
- McKeown, N.M.; Jacques, P.F.; Zhang, X.L.; Juan, W.; Sahyoun, N.R. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur. J. Nutr. 2008, 47, 210–216. [Google Scholar] [CrossRef] [PubMed]
- Volpe, S.L. Magnesium in disease prevention and overall health. Adv. Nutr. 2013, 4, 378S–383S. [Google Scholar] [CrossRef] [PubMed]
- Hadjistavri, L.S.; Sarafidis, P.A.; Georgianos, P.I.; Tziolas, I.M.; Aroditis, C.P.; Hitoglou-Makedou, A.; Zebekakis, P.E.; Pikilidou, M.I.; Lasaridis, A.N. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med. Sci. Monit. 2010, 16, CR307–CR312. [Google Scholar] [PubMed]
- Song, Y.; He, K.; Levitan, E.B.; Manson, J.E.; Liu, S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: A meta-analysis of randomized double-blind controlled trials. Diabet. Med. 2006, 23, 1050–1056. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Persuitte, G.; Olendzki, B.C.; Wedick, N.M.; Zhang, Z.; Merriam, P.A.; Fang, H.; Carmody, J.; Olendzki, G.F.; Ma, Y. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients 2013, 5, 3910–3919. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Suárez, A.; Pulido, N.; Casla, A.; Casanova, B.; Arrieta, F.J.; Rovira, A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995, 38, 1262–1270. [Google Scholar] [CrossRef] [PubMed]
- Hruby, A.; Ngwa, J.S.; Renström, F.; Wojczynski, M.K.; Ganna, A.; Hallmans, G.; Houston, D.K.; Jacques, P.F.; Kanoni, S.; Lehtimäki, T.; et al. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 charge consortium studies. J. Nutr. 2013, 143, 345–353. [Google Scholar] [CrossRef] [PubMed]
- Kass, L.; Weekes, J.; Carpenter, L. Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur. J. Clin. Nutr. 2012, 66, 411–418. [Google Scholar] [CrossRef] [PubMed]
- Soltani, N.; Keshavarz, M.; Dehpour, A.R. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat. Eur. J. Pharmacol. 2007, 560, 201–205. [Google Scholar] [CrossRef] [PubMed]
- Olatunji, L.A.; Soladoye, A.O. Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats. Pathophysiology 2007, 14, 11–15. [Google Scholar] [CrossRef] [PubMed]
- Bo, S.; Pisu, E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr. Opin. Lipidol. 2008, 19, 50–56. [Google Scholar] [CrossRef] [PubMed]
- Beydoun, M.A.; Gary, T.L.; Caballero, B.H.; Lawrence, R.S.; Cheskin, L.J.; Wang, Y. Ethnic differences in dairy and related nutrient consumption among us adults and their association with obesity, central obesity, and the metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 1914–1925. [Google Scholar] [PubMed]
- Drenick, E.J. The influence of ingestion of calcium and other soap-forming substances on fecal fat. Gastroenterology 1961, 41, 242–244. [Google Scholar] [PubMed]
- Cahill, F.; Shahidi, M.; Shea, J.; Wadden, D.; Gulliver, W.; Randell, E.; Vasdev, S.; Sun, G. High dietary magnesium intake is associated with low insulin resistance in the newfoundland population. PLoS One 2013. [Google Scholar] [CrossRef] [Green Version]
- Freedman, L.S.; Schatzkin, A.; Wax, Y. The impact of dietary measurement error on planning sample size required in a cohort study. Am. J. Epidemiol. 1990, 132, 1185–1195. [Google Scholar] [PubMed]
- Freudenheim, J.L.; Marshall, J.R. The problem of profound mismeasurement and the power of epidemiological studies of diet and cancer. Nutr. Cancer 1988, 11, 243–250. [Google Scholar] [CrossRef] [PubMed]
- Höfler, M. The effect of misclassification on the estimation of association: A review. Int. J. Methods Psychiatr. Res. 2005, 14, 92–101. [Google Scholar] [CrossRef] [PubMed]
- Copeland, K.T.; Checkoway, H.; McMichael, A.J.; Holbrook, R.H. Bias due to misclassification in the estimation of relative risk. Am. J. Epidemiol. 1977, 105, 488–495. [Google Scholar] [PubMed]
- Thompson, F.E.; Kipnis, V.; Midthune, D.; Freedman, L.S.; Carroll, R.J.; Subar, A.F.; Brown, C.C.; Butcher, M.S.; Mouw, T.; Leitzmann, M.; et al. Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) diet and health study. Public Health Nutr. 2008, 11, 183–195. [Google Scholar] [PubMed]
- Dong, J.Y.; Xun, P.; He, K.; Qin, L.Q. Magnesium intake and risk of type 2 diabetes: Meta-analysis of prospective cohort studies. Diabetes Care 2011, 34, 2116–2122. [Google Scholar] [CrossRef] [PubMed]
- Qu, X.; Jin, F.; Hao, Y.; Li, H.; Tang, T.; Wang, H.; Yan, W.; Dai, K. Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies. PLoS One 2013. [Google Scholar] [CrossRef]
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ju, S.-Y.; Choi, W.-S.; Ock, S.-M.; Kim, C.-M.; Kim, D.-H. Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression. Nutrients 2014, 6, 6005-6019. https://doi.org/10.3390/nu6126005
Ju S-Y, Choi W-S, Ock S-M, Kim C-M, Kim D-H. Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression. Nutrients. 2014; 6(12):6005-6019. https://doi.org/10.3390/nu6126005
Chicago/Turabian StyleJu, Sang-Yhun, Whan-Seok Choi, Sun-Myeong Ock, Chul-Min Kim, and Do-Hoon Kim. 2014. "Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression" Nutrients 6, no. 12: 6005-6019. https://doi.org/10.3390/nu6126005
APA StyleJu, S.-Y., Choi, W.-S., Ock, S.-M., Kim, C.-M., & Kim, D.-H. (2014). Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression. Nutrients, 6(12), 6005-6019. https://doi.org/10.3390/nu6126005